The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
Open accessAbstract
Historically, it has been difficult to propagate cells in vitro that are derived directly from human tumors or healthy tissue. However, in vitro preclinical models are essential tools for both the study of basic cancer biology and the promotion of translational research, including drug discovery and drug target identification. This protocol describes conditional reprogramming (CR), which involves coculture of irradiated mouse fibroblast feeder cells with normal and tumor human epithelial cells in the presence of a Rho kinase inhibitor (Y-27632). CR cells can be used for various applications, including regenerative medicine, drug sensitivity testing, gene expression profiling and xenograft studies. The method requires a pathologist to differentiate healthy tissue from tumor tissue, and basic tissue culture skills. The protocol can be used with cells derived from both fresh and cryopreserved tissue samples. As approximately 1 million cells can be generated in 7 d, the technique is directly applicable to diagnostic and predictive medicine. Moreover, the epithelial cells can be propagated indefinitely in vitro, yet retain the capacity to become fully differentiated when placed into conditions that mimic their natural environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,289
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447
Lessons from the Cancer Genome
Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308
Patient-derived tumour xenografts as models for oncology drug development
Tentler, J. J., Tan, A. C., Weekes, C. D., Jimeno, A., Leong, S., Pitts, T. M., Arcaroli, J. J., Messersmith, W. A., & Eckhardt, S. G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.61 · Cited by 1,277
Sequential cancer mutations in cultured human intestinal stem cells
Drost, J., van Jaarsveld, R. H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A., Sachs, N., Overmeer, R. M., Offerhaus, G. J., Begthel, H., et al. (2015) · Nature · doi:10.1038/nature14415 · Cited by 1,067
Hata, A. N., Niederst, M. J., Archibald, H. L., Gomez-Caraballo, M., Siddiqui, F. M., Mulvey, H. E., Maruvka, Y. E., Ji, F., Bhang, H.-E. C., Krishnamurthy Radhakrishna, V., et al. (2016) · Nature Medicine · doi:10.1038/nm.4040 · Cited by 985
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., Timofeeva, O. A., Nealon, C., Dakic, A., Simic, V., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.036 · Cited by 726
Self-citationPatient-derived models of acquired resistance can identify effective drug combinations for cancer
Crystal, A. S., Shaw, A. T., Sequist, L. V., Friboulet, L., Niederst, M. J., Lockerman, E. L., Frias, R. L., Gainor, J. F., Amzallag, A., Greninger, P., et al. (2014) · Science · doi:10.1126/science.1254721 · Cited by 708
Senescence and immortalization: Role of telomeres and telomerase
Shay, J. W., & Wright, W. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh296 · Cited by 610
The Clinical Relevance of Cancer Cell Lines
Gillet, J.-P., Varma, S., & Gottesman, M. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt007 · Cited by 599
Precision medicine for cancer with next-generation functional diagnostics
Friedman, A. A., Letai, A., Fisher, D. E., & Flaherty, K. T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4015 · Cited by 570
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture
Li, X., Nadauld, L., Ootani, A., Corney, D. C., Pai, R. K., Gevaert, O., Cantrell, M. A., Rack, P. G., Neal, J. T., Chan, C. W.-M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3585 · Cited by 442
Self-citationCancer Cell Lines for Drug Discovery and Development
Wilding, J. L., & Bodmer, W. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2971 · Cited by 432
The two-stage mechanism controlling cellular senescence and immortalization
Wright, W. E., & Shay, J. W. (1992) · Experimental Gerontology · doi:10.1016/0531-5565(92)90069-c · Cited by 383
Organoid cultures for the analysis of cancer phenotypes
Sachs, N., & Clevers, H. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 371
Cellular transformation by SV40 large T antigen: interaction with host proteins
Ali, S. H., & DeCaprio, J. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0342 · Cited by 367
Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor
Chapman, S., Liu, X., Meyers, C., Schlegel, R., & McBride, A. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42297 · Cited by 315
Self-citationConditionally reprogrammed cells represent a stem-like state of adult epithelial cells
Suprynowicz, F. A., Upadhyay, G., Krawczyk, E., Kramer, S. C., Hebert, J. D., Liu, X., Yuan, H., Cheluvaraju, C., Clapp, P. W., Boucher, R. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213241109 · Cited by 291
Self-citationHuman Nasal and Tracheo-Bronchial Respiratory Epithelial Cell Culture
Fulcher, M. L., & Randell, S. H. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-125-7_8 · Cited by 284
Self-citationMammary stem cells have myoepithelial cell properties
Prater, M. D., Petit, V., Alasdair Russell, I., Giraddi, R. R., Shehata, M., Menon, S., Schulte, R., Kalajzic, I., Rath, N., Olson, M. F., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3025 · Cited by 240
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Jin, K., Teng, L., Shen, Y., He, K., Xu, Z., & Li, G. (2010) · Clinical and Translational Oncology · doi:10.1007/s12094-010-0540-6 · Cited by 217
Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering
Butler, C. R., Hynds, R. E., Gowers, K. H. C., Lee, D. D. H., Brown, J. M., Crowley, C., Teixeira, V. H., Smith, C. M., Urbani, L., Hamilton, N. J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1414oc · Cited by 216
Williams, S. A., Anderson, W. C., Santaguida, M. T., & Dylla, S. J. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.92 · Cited by 186
Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis
Yuan, H., Myers, S., Wang, J., Zhou, D., Woo, J. A., Kallakury, B., Ju, A., Bazylewicz, M., Carter, Y. M., Albanese, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203055 · Cited by 169
Self-citationThree-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment
Herrmann, D., Conway, J. R. W., Vennin, C., Magenau, A., Hughes, W. E., Morton, J. P., & Timpson, P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu108 · Cited by 144
Nadauld, L. D., Garcia, S., Natsoulis, G., Bell, J., Miotke, L. K., Hopmans, E. S., Xu, H., Pai, R. K., Palm, C., Regan, J. F., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0428-9 · Cited by 129
Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
Schmidt, F., & Efferth, T. (2016) · Pharmaceuticals · doi:10.3390/ph9020033 · Cited by 122
Palechor-Ceron, N., Suprynowicz, F. A., Upadhyay, G., Dakic, A., Minas, T. Z., Simić, V., Johnson, M. D., Albanese, C., Schlegel, R., & Liu, X. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.009 · Cited by 120
Self-citationChu, H. W., Rios, C. L., Huang, C.-J., Wesolowska‐Andersen, A., Burchard, E. G., O’Connor, B. P., Fingerlin, T. E., Nichols, D. P., Reynolds, S. D., & Seibold, M. A. (2015) · Gene Therapy · doi:10.1038/gt.2015.53 · Cited by 102
Saeed, K., Rahkama, V., Eldfors, S., Bychkov, D., Mpindi, J. P., Yadav, B., Paavolainen, L., Aittokallio, T. A., Heckman, C. A., Wennerberg, K., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.04.019 · Cited by 89
Charette, S. T., & McCance, D. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210541 · Cited by 76
An ecosystem of cancer cell line factories to support a cancer dependency map
Boehm, J. S., & Golub, T. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3967 · Cited by 75
Terunuma, A., Limgala, R. P., Park, C. J., Choudhary, I., & Vogel, J. C. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0339 · Cited by 71
Methods of induced pluripotent stem cells for clinical application
Seki, T., & Fukuda, K. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.116 · Cited by 71
McAuliffe, P. F., Evans, K. W., Akçakanat, A., Chen, K., Zheng, X., Zhao, H., Eterovic, A. K., Sangai, T., Holder, A. M., Sharma, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136851 · Cited by 69
Thangapazham, R. L., Klover, P. J., Wang, J.-A., Zheng, Y., Devine, A., Li, S., Sperling, L. C., Cotsarelis, G., & Darling, T. N. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.337 · Cited by 69
Self-citationThe ethics of stem cells revisited
Beriaín, Í. D. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.011 · Cited by 65
Beglyarova, N., Banina, E., Zhou, Y., Mukhamadeeva, R., Andrianov, G. V., Bobrov, E., Lysenko, E., Skobeleva, N., Gabitova, L., Restifo, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0149 · Cited by 64
Preclinical models in radiation oncology
Kahn, J. M., Tofilon, P. J., & Camphausen, K. A. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-223 · Cited by 63
Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect
Veit, G., Oliver, K. E., Apaja, P. M., Perdomo, D., Bidaud-Meynard, A., Lin, S.-T., Guo, J., Icyuz, M., Sorscher, E. J., Hartman, J. L., et al. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002462 · Cited by 55
Ovarian and cervical cancer patient derived xenografts: The past, present, and future
Boone, J. D., Dobbin, Z. C., Straughn, J. M., & Buchsbaum, D. J. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.05.022 · Cited by 51
Using induced pluripotent stem cells as a tool for modelling carcinogenesis
Curry, E. L. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.461 · Cited by 40
Yue, J., Shukla, R., Accardi, R., Zanella‐Cléon, I., Siouda, M., Cros, M., Krutovskikh, V. A., Hussain, I., Niu, Y., Hu, S., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02561-10 · Cited by 33
Patient-derived bladder cancer xenografts: a systematic review
Bernardo, C., Costa, C., Sousa, N., Amado, F. M. L., & Santos, L. L. (2015) · Translational research · doi:10.1016/j.trsl.2015.02.001 · Cited by 31
Developing in vitro models of human ductal carcinoma in situ from primary tissue explants
Brown, D. D., Dabbs, D. J., Lee, A. V., McGuire, K. P., Ahrendt, G. M., Bhargava, R., Davidson, N. E., Brufsky, A., Johnson, R. R., Oesterreich, S., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3551-8 · Cited by 23
A model system to analyse the ability of human keratinocytes to form hair follicles
Thangapazham, R. L., Klover, P. J., Li, S., Wang, J., Sperling, L. C., & Darling, T. N. (2014) · Experimental Dermatology · doi:10.1111/exd.12424 · Cited by 22
Self-citationWalters, B. J., Diao, S., Zheng, F., Walters, B. J., Layman, W. S., & Zuo, J. (2015) · Scientific Reports · doi:10.1038/srep17792 · Cited by 22
Issues to be considered when studying cancer in vitro
Čunderlíková, B. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.06.007 · Cited by 16
Cited by
Yoo, H. C., Park, S. J., Nam, M., Kang, J., Kim, K., Yeo, J. H., Kim, J.-K., Heo, Y., Lee, H. S., Lee, M. Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.020 · Cited by 449
Patient derived organoids to model rare prostate cancer phenotypes
Puca, L., Bareja, R., Prandi, D., Shaw, R., Benelli, M., Karthaus, W. R., Hess, J., Sigouros, M., Donoghue, A., Kossai, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04495-z · Cited by 361
A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
Weiskirchen, S., Schröder, S. K., Buhl, E. M., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12050682 · Cited by 148
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Veit, G., Xu, H., Dreano, E., Avramescu, R. G., Bagdany, M., Beitel, L. K., Roldan, A., Hancock, M. A., Lay, C., Li, W., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0200-x · Cited by 134
Sirois, I., Aguilar-Mahecha, A., Lafleur, J., Fowler, E., Vu, V., Scriver, M., Buchanan, M., Chabot, C., Ramanathan, A., Balachandran, B., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0264 · Cited by 110
Metadata
- Authors
- Liu, X., Krawczyk, E., Suprynowicz, F. A., Palechor-Ceron, N., Yuan, H., Dakic, A., Simic, V., Zheng, Y.-L., Sripadhan, P., Chen, C., Lu, J., Hou, T.-W., Choudhury, S., Kallakury, B., Tang, D. G., Darling, T., Thangapazham, R., Timofeeva, O., Dritschilo, A., Randell, S. H., Albanese, C., Agarwal, S., & Schlegel, R.
- Venue
- Nature Protocols
- Published
- 2017-01-26
- Volume
- 12
- Issue
- 2
- Pages
- 439-451
- ISSN
- 1750-2799 (ISSN-L)
- 1754-2189
- OpenAlex
- W2581675136
- Cited by
- 299
- References
- 52
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
